Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Baricitinib may effectively treat nail changes in alopecia areata.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A woman's hair turned white after taking a cancer drug called dasatinib.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

ZD1839 can cause skin issues like acne and hair changes.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Rituximab improved her dermatomyositis better than usual treatments.